SPC338
Inclisíran
Status:
VeittApplication date:
4.6.2021Application published:
15.7.2021Grant published:
15.4.2024
Max expiry date:
9.12.2035Medicine name:
LeqvioMedicine for children:
No
Timeline
Today
4.6.2021Application
15.7.2021Publication
15.4.2024Registration
9.12.2035Expires
Marketing license
IS authorization number:
EU/1/20/1494/001Date:
5.1.2021
Foreign authorization number:
EU/1/20/1494Date:
9.12.2020
Owner
Name:
Alnylam Pharmaceuticals, Inc.Address:
675 West Kendall Street, Henri A. Termeer Square, Cambridge US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2929031